CYTOKINETICS, INCORPORATED (CYTK)

72.09 -7.46% (-5.81)

Over 5Y: +125.6%

2026-08-28
25 50 75 100
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '21 — Revenue: 5.4M Q3 '21 — Operating Cash Flow: -38.8M Q3 '21 — Free Cash Flow: -54.5M Q3 '21 — Net Income: -76.1M Q4 '21 — Revenue: 55.6M Q4 '21 — Operating Cash Flow: -44.7M Q4 '21 — Free Cash Flow: -62.5M Q4 '21 — Net Income: -30.6M Q1 '22 — Revenue: 1.1M Q1 '22 — Operating Cash Flow: -26.8M Q1 '22 — Free Cash Flow: -27.8M Q1 '22 — Net Income: -89.4M Q2 '22 — Revenue: 89M Q2 '22 — Operating Cash Flow: -90.5M Q2 '22 — Free Cash Flow: -91.3M Q2 '22 — Net Income: -19.8M Q3 '22 — Revenue: 2.5M Q3 '22 — Operating Cash Flow: -84M Q3 '22 — Free Cash Flow: -90.4M Q3 '22 — Net Income: -142.3M Q4 '22 — Revenue: 2M Q4 '22 — Operating Cash Flow: -98.2M Q4 '22 — Free Cash Flow: -101.4M Q4 '22 — Net Income: -137.4M Q1 '23 — Revenue: 4.6M Q1 '23 — Operating Cash Flow: -122.3M Q1 '23 — Free Cash Flow: -122.7M Q1 '23 — Net Income: -131.3M Q2 '23 — Revenue: 867K Q2 '23 — Operating Cash Flow: -121.8M Q2 '23 — Free Cash Flow: -122.5M Q2 '23 — Net Income: -128.6M Q3 '23 — Revenue: 378K Q3 '23 — Operating Cash Flow: -96.2M Q3 '23 — Free Cash Flow: -96.4M Q3 '23 — Net Income: -129.4M Q4 '23 — Revenue: 1.7M Q4 '23 — Operating Cash Flow: -74M Q4 '23 — Free Cash Flow: -74.1M Q4 '23 — Net Income: -136.9M Q1 '24 — Revenue: 835K Q1 '24 — Operating Cash Flow: -129.5M Q1 '24 — Free Cash Flow: -129.5M Q1 '24 — Net Income: -135.6M Q2 '24 — Revenue: 249K Q2 '24 — Operating Cash Flow: -99.3M Q2 '24 — Free Cash Flow: -101.2M Q2 '24 — Net Income: -143.3M Q3 '24 — Revenue: 463K Q3 '24 — Operating Cash Flow: -101.5M Q3 '24 — Free Cash Flow: -102.2M Q3 '24 — Net Income: -160.5M Q4 '24 — Revenue: 16.9M Q4 '24 — Operating Cash Flow: -65.6M Q4 '24 — Free Cash Flow: -66.9M Q4 '24 — Net Income: -150M Q1 '25 — Revenue: 1.6M Q1 '25 — Operating Cash Flow: -131.6M Q1 '25 — Free Cash Flow: -137.3M Q1 '25 — Net Income: -161.4M Q2 '25 — Revenue: 66.8M Q2 '25 — Operating Cash Flow: -128.2M Q2 '25 — Free Cash Flow: -132.4M Q2 '25 — Net Income: -134.4M Q3 '25 — Revenue: 1.9M Q3 '25 — Operating Cash Flow: -107.5M Q3 '25 — Free Cash Flow: -116.9M Q3 '25 — Net Income: -306.2M Q4 '25 — Revenue: 17.8M Q4 '25 — Operating Cash Flow: -142.7M Q4 '25 — Free Cash Flow: -148.3M Q4 '25 — Net Income: -183M Q1 '26 — Revenue: 19.4M Q1 '26 — Operating Cash Flow: -145.5M Q1 '26 — Free Cash Flow: -151.4M Q1 '26 — Net Income: -206M Q2 '26 — Revenue: 28.6M Q2 '26 — Operating Cash Flow: -159.8M Q2 '26 — Free Cash Flow: -164.2M Q2 '26 — Net Income: -198.8M -240M -160M -80M 0 80M 160M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 188.1%
OE margin -1046.3%
Oper. margin -1046.1%
Accruals -17.6%
Asset turnover 0.035×
EBITDA margin -1027.6%
FCF margin -858.2%
OCF margin -820.8%
Profit margin -1321.1%
ROA -46.5%
ROCE -40.6%
Gross margin —
OCF / EBIT —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.2
RPO / sales 0.024×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -28.5×
Cash / Debt 4.2×
Debt payback 0.0 yr
Quick ratio 6.7×
Cash runway 1.5 yr
F-score 2.2 pts
Debt / Eq —
Equity / Assets —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.2
Sales/sh Y/Y -26.4%
Sales Q/Q -57.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.